IDE Monoclonal Antibody (3H4) Sizes: 50μL, 100μL Catalogue Numbers: RA10628-50, RA10628-100 Lead times: 1-2 weeks, if manufacturer has product in stock Manufacturer/Ship Location: China Background: insulin degrading enzyme (IDE) Homo sapiens This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been describe Reactivity: Human Host: Mouse Applications: WB, IHC-p, IF/ICC, Alternate Names: IDE, Insulin-degrading enzyme, Abeta-degrading protease, Insulin protease, Insulinase, Insulysin Clonality: Monoclonal Dilution: WB: 1:1000 IF 1:200 IHC 1:50-300 Storage: -20°C/1 year Condition: PBS, pH 7.4, containing 0.5% BSA, 0.02% sodium azide as Preservative and 50% Glycerol. Human Gene ID: 3416 Protein Molecular Weight（KDa): 118 Molecular Weight: 118 Research Use Only